** Citi analysts lower price target for nib Holdings NHF.AX to A$6.9; retain "neutral" rating

** The medical insurer, nib, on Tuesday said it now expects an operating loss for its New Zealand business instead of the previously expected profit

** Citi sees an A$2 million ($1.30 million) underlying operating loss for co's New Zealand unit

** Brokerage expects co to make A$236 million in FY25 underlying operating profit, near the lower end of nib's retained guidance range

** Also reduces FY25 and FY26 earnings per share estimate by 4% and 2%, respectively

** 5 out of 11 analysts rate the stock "hold", 5 rate it "buy" or higher, 1 rates its "sell"; median PT is A$7.03 - data compiled by LSEG

** Stock last up 25.2% YTD

($1 = 1.5418 Australian dollars)

(Reporting by Jasmeen Ara Shaikh in Bengaluru)

((JasmeenAraIslam.Shaikh@thomsonreuters.com;))